Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy
Top Cited Papers
Open Access
- 1 November 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (9) , 1300-1306
- https://doi.org/10.1086/425004
Abstract
Background. Community-acquired respiratory viruses, such as influenza virus, are thought to be major causes of morbidity and mortality in patients whKeywords
This publication has 20 references indexed in Scilit:
- Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantationBone Marrow Transplantation, 2003
- Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trialsBMJ, 2003
- Low mortality rates related to respiratory virus infections after bone marrow transplantationBone Marrow Transplantation, 2003
- Prolonged Shedding of Multidrug-Resistant Influenza A Virus in an Immunocompromised PatientNew England Journal of Medicine, 2003
- Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factorsBlood, 2002
- Viral infections in immunocompromised patients: whatʼs new with respiratory viruses?Current Opinion in Infectious Diseases, 2002
- The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantationBone Marrow Transplantation, 2002
- Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2001
- Common Emergence of Amantadine‐ and Rimantadine‐Resistant Influenza A Viruses in Symptomatic Immunocompromised AdultsClinical Infectious Diseases, 1998
- Influenza A in Immunocompromised PatientsClinical Infectious Diseases, 1993